About Decina Pharma Private Limited
Data last updated:
Decina Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2017PTC170011. Its GSTIN is 27AAGCD1401P1ZN (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sherrin Pulikathotil James and Jaji Puthen Parambil James.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 108 Building No.G S.No.73/1 Geras Emerald City South Kharadi, Pune, Maharashtra, India – 411014.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.73 Cr, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹30.48 Lakh (net margin -17.6%) and EBITDA of -₹19.22 Lakh (EBITDA margin -11.1%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 1% over five years.
The company is associated with 1 brand: Decina Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website decinapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressFlat No. 108 Building No.G S.No.73/1 Geras Emerald City South Kharadi, Pune, Maharashtra, India – 411014
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Decina Pharma Private Limited
The main business activity of Decina Pharma is other service activities. In detail, this covers activities of membership organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| S | Other service activities | 94 | Activities of membership organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Decina Pharma Private Limited FY 2025 filings available
Decina Pharma Private Limited reported revenue of ₹1.73 Cr (down 51% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Decina Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 51% fall in the latest year. EBITDA fell 194% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Decina Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹19.22 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹30.48 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Decina Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -17.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Decina Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Decina Pharma Private Limited
Decina Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Divine Formulations Private Limited | ₹1.74 Cr (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Adam Laboratories Private Limited | ₹1.74 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Uttar Pradesh, India |
| Medicone Formulations Private Limited | ₹1.74 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Sandmartin Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | New Delhi, Delhi, India |
| Rex Medicare Private Limited | ₹1.73 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| Decina Pharma Private Limited this company | ₹1.73 Cr (FY 2025) | •••• | •••• | -51.0% | •••• | Pune, Maharashtra, India |
| Kosford Pharmaceuticals Private Limited | ₹1.73 Cr (FY 2025) | •••• | •••• | 88.0% | •••• | Vadodara, Gujarat, India |
| Unimedia Pharmaceuticals Private Limited | ₹1.73 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Ahmedabad, Gujarat, India |
| Gleanboots Life Science Private Limited | ₹1.72 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Delhi, India |
| Aman Formulations Private Limited | ₹1.72 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Badaun, Uttar Pradesh, India |
| Valens Wellbeing Private Limited | ₹1.72 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Decina Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Decina Pharma Private Limited
Decina Pharma Private Limited is audited by TEENA SINGHAL GOVILA & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| TEENA SINGHAL GOVILA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Decina Pharma Private Limited
Decina Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sherrin Pulikathotil James Also directs: Tanishka Sanitary Products LLP | Director | 20 Apr 2017 | 9 Years 5 Months | Current |
| Jaji Puthen Parambil James Also directs: Tanishka Sanitary Products LLP | Director | 20 Apr 2017 | 9 Years 5 Months | Current |
Ownership and Shareholding of Decina Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Decina Pharma Private Limited
Decina Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Decina Pharma Private Limited
Decina Pharma operates one associated brand: Decina Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Global supplier of pharmaceutical API and formulations with a focus on quality and supply chain management. | decinapharma.com |
Employees and EPFO Compliance at Decina Pharma Private Limited
Employment history and EPFO contributions of people linked to Decina Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Decina Pharma Private Limited
Decina Pharma Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Het Sanjay Sanghavi ceased to be Director on 02 Jun 2021.
Credit Ratings, Litigation & Regulatory Alerts for Decina Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Decina Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Decina Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Decina Pharma Private Limited
Decina Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD1401P1ZN | Maharashtra | Active | 29 Sep 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Decina Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Decina Pharma Private Limited
Decina Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 April 2017 (9+ years old) and is registered under CIN U51909PN2017PTC170011.
Decina Pharma reported revenue of ₹1.73 Cr for FY 2025 (down 51% YoY).
Decina Pharma has 2 current directors:
- Sherrin Pulikathotil James - Director
- Jaji Puthen Parambil James - Director
Decina Pharma reported a net loss of ₹30.48 Lakh (net margin -17.6%) and EBITDA of -₹19.22 Lakh (EBITDA margin -11.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Decina Pharma is -7% over three years and -1% over five years. In the latest year (FY 2025) revenue fell 51%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Decina Pharma is 27AAGCD1401P1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Decina Pharma is U51909PN2017PTC170011. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Decina Pharma was incorporated on 20 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Decina Pharma by revenue are Divine Formulations Private Limited, Adam Laboratories Private Limited, Medicone Formulations Private Limited, Sandmartin Pharmaceuticals Private Limited, Rex Medicare Private Limited and 5 more, all in the Pharma industry (Formulations).
Het Sanjay Sanghavi ceased to be Director on 02 Jun 2021. Karan M Trivedi ceased to be Director on 02 Jun 2021. Pratik Hasmukhray Doshi ceased to be Director on 02 Jun 2021. Decina Pharma has 5 board changes on record in total.
Decina Pharma can be reached through the website decinapharma.com. Its registered office is in Pune, Maharashtra, India.